CYTOO
Alice Gutjahr currently serves as the Director of Partnerships at CYTOO and has a background in project management, scientific research, and immunology. With experience in leading interdisciplinary teams, defining project strategies, and presenting at international conferences, Alice has a strong foundation in biotechnology and therapeutic innovation. Alice's academic journey includes degrees in biotechnology, immunology, and project management, showcasing their dedication to continuous learning and professional growth.
This person is not in any teams
CYTOO
CYTOO is a preclinical stage drug discovery company specialized in muscular and neuromuscular disorders. CYTOO partners its versatile patient-derived muscle drug discovery engine to pharma and biotech companies and develops its own drug candidates. CYOO has developed a fully mature human in vitro muscle model (MyoScreen) derived from primary human samples (healthy and pathological myoblasts) for generating NCEs from a variety of pathological conditions (rare, chronic). Core expertise lies on in vitro muscle regeneration, contraction, hypertrophy, and metabolism.